The Food and Drug Administration has approved a drug made by Sunovion and Dainippon Sumitomo Pharma Co. for bipolar disorder, Sunovion said.
Mylan has launched a generic drug used to treat sleep disorders, the company said Friday.
Mylan has launched generic versions of two drugs to treat bipolar disorder and allergies, the company said Tuesday.
Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.
A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.
Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.
Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.
A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.
Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.
The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.
AstraZeneca is launching a new campaign focused on depression, the Anglo-Swedish drug maker said Thursday....
Off-label use of atypical antipsychotics may increase the risk of developing diabetes among the elderly,...
A state judge in New Jersey has ruled in favor of AstraZeneca in the case...
An inhaled mental health drug could appear on the market in the near future under...